References
- Hauschke D., Steinijans V. W., Diletti E. A distribution-free procedure for the statistical analysis of bioequivalence studies. Int. J. Pharmacol. Ther. Toxicol. 1990; 28: 72–78
- Hauschke D., Steinijans V. W. Ein verteilungsfreies Verfahren zur statistischen Auswertung von Bioäquivalenzstudien. Biometrie in der chemisch-pharmazeutischen Industrie, Band 5, Statistische Beurteilung der Bioäquivalenz sofort freisetzender Arzneiformen. Gustav Fischer, StuttgartGermany 1991
- Steinijans V. W., Hauschke D. Update on the statistical analysis of bioequivalence studies. Int. J. Clin. Pharmacol. Ther. Toxicol. 1990; 28: 105–110
- Wijnand H. P. Bioequivalence revisited: Non-parametric analysis of two-period cross-over studies. Computer Meth. Progr. Biomed. 1993; 40: 249–259
- Wijnand H. P. Bioequivalence assessment of drug formulations: Non-parametric versus parametric analysis. State University of Leiden, The Netherlands 30 June, 1994, Doctoral thesis
- U.S. Food and Drug Administration Guidance. Statistical procedures for bioequivalence studies using a standard two-treatment crossover design. 29 June, 1992, Statement under 21 CFR 10.90
- Commission on the European Communities, CPMP Working Party on Efficacy of Medicinal Products. Note for Guidance, Investigation of Bioavailability and Bioequivalence. December, 1991, III/54/89-EN
- Wijnand H. P. Updates of bioequivalence programs (including statistical power approximated by Student's t). Computer Meth. Progr. Biomed. 1994; 42: 275–281